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Abstract 
 
Purpose of review 
There is growing interest in applying metabolic profiling technologies to food science 
as this approach is now embedded into the foodomics toolbox. This review aims at 
exploring how metabolic profiling can be applied to the development of functional 
foods. 
 
Recent findings 
One of the biggest challenges of modern nutrition is to propose a healthy diet to 
populations worldwide that must suit high inter-individual variability driven by 
complex gene-nutrient-environment interactions. Although a number of functional 
foods are now proposed in support of a healthy diet, a one-size-fits-all approach to 
nutrition is inappropriate and new personalised functional foods are necessary. 
Metabolic profiling technologies can assist at various levels of the development of 
functional foods, from screening for food composition to identification of new 
biomarkers of food intake to support diet intervention and epidemiological studies. 
 
Summary 
Modern ‘omics’ technologies, including metabolic profiling, will support the 
development of new personalised functional foods of high relevance to twenty-first-
century medical challenges such as controlling the worldwide spread of metabolic 
disorders and ensuring healthy ageing. 
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Introduction 
 
The term “functional food” can be defined as a food product that confers 
some beneficial effects on health beyond the basic nutritional values of food [1]. As 
such, it is sometimes difficult to determine whether a food product should be 
classified or not as “functional”. Functional food can therefore be either naturally rich 
or artificially enriched in substances (living organisms or nutrients) that are known for 
their beneficial effects such as probiotics, prebiotics, essential fatty acids, flavonoids, 
vitamins etc. In this regard, many natural products can be considered “functional” 
such as milk, numerous fruits and vegetables and oily fishes. To determine whether 
a food product has any specific health beneficial effect, one must measure the health 
impact of a complex food matrix following digestion (Figure 1). This can be achieved 
by measuring a number of physiological and biochemical parameters following diet 
intervention studies or epidemiologic surveys in relation with health outcome (e.g. 
HDL-LDL ratio in relation with cardiovascular disease). However, testing individuals 
with various genetic backgrounds results in high inter-individual variability and makes 
it difficult to detect subtle metabolic variations induced by a specific food intake. In 
addition, the gut microbiota is a highly variable environmental factor that must be 
considered as it inevitably interacts with the digestive process and may influence the 
overall outcome of ingested food. 
These complex gene-nutrient-environment interactions are the same 
challenges that Linus Pauling faced in 1971 when he developed a new technique to 
enable “the thorough quantitative analysis of body fluids” that “might permit 
differential diagnosis of many diseases in a more effective way than is possible at the 
present time” [2]. In this pioneering publication, Pauling laid the foundations of a new 
analytical field that would lead to the development of modern metabolic profiling 
technologies [3]. Indeed, using a hypothesis-generating approach based on the 
untargeted measurement of the ensemble of metabolites present in a biological 
sample, also called metabolomics or metabolic fingerprinting, has proved extremely 
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useful over the last decade in identifying potential disease markers [4] and is now 
embedded into the “foodomics” toolbox [5]. Hence, beyond its applications in the 
medical field, metabolic profiling can be applied at various stages of the development 
of new functional foods, as illustrated in Figure 1. This review will therefore explore 
how metabolic profiling has been recently applied to reveal the metabolic 
composition of potential functional food products or to support identification of new 
candidates. We will describe how it contributes to the assessment of the gut 
microbial metabolic activity and supports measurements of the metabolic outcomes 
of diet intervention studies and epidemiological surveys. 
Understanding food composition for screening of new functional ingredients 
 
Metabolomics is a powerful approach to metabolically characterise existing or 
potential functional food candidates. Not only can such approach contribute to 
improve our understanding of food product composition and bioaccessibility of their 
components, [6] but it may also reveal a number of unknown metabolites, particularly 
secondary metabolites in plants, that may be biologically active [7].  
For instance, there is a growing interest in milk characterisation using modern 
metabolic profiling technologies (i.e. proton Nuclear Magnetic Resonance 
spectroscopy and Mass Spectrometry-based profiling) to better understand its 
formation and composition [8-11]. Milk is a complex food matrix that has been 
extensively studied for its major components (i.e. proteins, fat, lactose) and some 
minor components (i.e. minerals and vitamins). Only recently has the milk water 
soluble fraction drawn interest as it contains small molecular weight metabolites that 
are of nutritional importance, including numerous oligosaccharides [12,13]. Milk 
oligosaccharides are of particular importance since they are biologically active and 
can favour the growth of beneficial lactic acid bacteria in the gut. [reviewed here: 
[14]] Because oligosaccharides are found in relatively low concentration in non-
human milk, most of the research effort over the last decade has been focused on 
the role of non-milk oligosaccharides such as plant-derived fructooligosaccharides 
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(FOS) and enzymatically synthesized galactooligosaccharides (GOS). However, 
recent technological improvements using tandem mass spectrometry have facilitated 
characterisation of non-human milk oligosaccharides and promising results have 
been obtained using bovine milk oligosaccharides as new functional ingredients [15-
17]. 
There is also an emerging interest in assessing the fermentation products of 
fermented milk and dairy derivatives, as it has been recently demonstrated that these 
products stimulate the infant’s immune system, even in absence of live bacteria 
[18,19]. Milk fermentation results in increased concentration of organic acids such as 
lactic acid, which are known to be beneficial as they lower the intestinal pH and 
protect against potential infections when fermentation occurs within the 
gastrointestinal tract. However, the active component of fermented milk derivatives is 
currently poorly understood. It is proposed that residual oligosaccharides produced 
from incomplete carbohydrate fermentation (i.e. sugars that are released by living 
organisms during the fermentation process but do not directly impart to the 
production of organic acids and other fermentation products) may have a prebiotic 
acitivity and contribute to the health promoting effect of these products. Another 
hypothesis is that bacteria themselves produce active compounds that would 
stimulate the immune system. These molecules are therefore of high importance as 
they may convene some health promoting activity and need to be further 
investigated. These are not specific to milk fermented derivatives and may be true for 
many other fermented food products, such as fermented soy derivatives. Metabolic 
profiling of fermented foods has been recognised as an appropriate strategy to 
identify potentially bioactive molecules [20]. Similarly, it has been recently attempted 
to use the same approach to rapidly screen for new functional food based on their 
prebiotic potential [21]. 
Finally, there has been a huge amount of research effort focused over the last 
decades on the identification of new probiotic species based on their effect on the 
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immune system and their metabolism (e.g. ability to produce high amounts of butyric 
acid). However, this is a long and tedious work that can be expensive. An alternative 
approach is to use metabolomics to screen large numbers of potential probiotic 
species to classify them based on their metabolic activity [22]. In the future, such 
approach will certainly support the discovery of new bacteria and nutrients that 
promote human health.  
 
Assisting diet-intervention studies for better control of compliance 
 
The most challenging aspect in the development of functional food is to 
identify the bioactivity of a specific foodstuff. This is classically achieved using diet 
intervention studies where a number of volunteers are given a proposed functional 
food to consume for various amounts of time. In such experiments, it is of utmost 
importance to accurately record participants’ diet over the course of the trial, which is 
classically achieved using a combination of three techniques: diet records, 24h 
dietary recalls and food frequency questionnaires [23]. The main issue associated 
with these methods is that they are all based on self-reported information, which is 
subject to bias and misreporting [24]. There is therefore a need for a more accurate 
estimation of dietary intake, which can be achieved by identifying specific biomarkers 
of food intake that can be employed to correct self-reported dietary information and 
control for compliance in diet restricted studies. 
In this regard, metabolic profiling has been widely applied in recent years to 
identify new biomarkers of food intake. Table 1 summarises the most recently 
published food biomarkers detected using a metabolomics approach. Some of these 
metabolites are now recognised markers, such as proline-betaine for citrus fruit 
consumption [25,26], and these studies either confirm previously identified food 
consumption biomarkers or suggest new ones that will need further validation. The 
main weakness associated with the food biomarker approach is that many of these 
are not food specific since they can be detected in a large number of related food 
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products. For example, hippuric acid and its derivatives are usually associated with 
vegetable intake as they derive from the degradation of plant polyphenols by the gut 
microbiota [27]. As a consequence, it is more accurate to refer to these substances 
as biomarkers of a food group, rather than a specific food product. Another approach 
is to use a combination (i.e. a profile) of markers that is more specific of a foodstuff or 
a diet. The research community is now increasingly aware of such limitations as 
illustrated by the recent publication of the Atherosclerosis Risk in Communities 
(ARIC) population study outcome [28]. Although researchers involved in the ARIC 
study reported some new food intake biomarkers, they clearly identified a set of 
markers associated with intake of “sugar-rich foods and beverages” (SRFB), which is 
also more meaningful in terms of biological interpretation. Similarly, a recent study 
used a metabolic profiling approach to identify various dietary traits in free-living 
subjects [29]. Although this is the first of its kind and further similar studies will be 
necessary to validate the profile of markers associated with each trait, this is a very 
encouraging work to better control for compliance in future diet intervention studies.  
 
Understanding food-mammalian metabolic interactions 
 
Some of the food intake biomarkers displayed in Table 1 are also 
endogenous compounds, such as scyllo-inositol, an ubiquitous component of cell 
membranes, or 5α-androstan-3β,17β-diol disulfate and 4-androsten-3β,17β-diol 
disulfate, which are sex hormone derivatives. The association of these chemicals 
with food intake may be due to confounding factors, but the ARIC study validated all 
potential biomarkers using an independent validation data set. Therefore, we may 
conclude that these chemicals are associated with the endogenous metabolic 
modulations triggered by the regular consumption of the food to which they were 
correlated. Indeed, nutrimetabonomics, defined as the quantitative measurement of 
the metabolic response of a living organism to a nutritional variation, is a powerful 
approach to generate new hypotheses of biological mechanisms underpinning food - 
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health interactions. This metabolic profiling approach, which focuses on the 
modulations of endogenous metabolic pathways associated with diet interventions, 
has been successfully applied to improve our understanding of a number of natural 
products, nutrients and food groups [30-34]. For example, of the 23 metabolites 
associated with the SRFB food group in the ARIC study, five were found to be γ-
glutamyl dipeptides and five were related to the 2-hydroxybutyrate pathway [28]. The 
authors therefore concluded that this was indicative of oxidative stress associated 
with the consumption of SRFB foods.  
Hence, the nutrimetabonomics approach is extremely useful to screen for 
markers of modulations of endogenous metabolic pathways in response to food 
intake. This is a powerful way to explore the impact of specific foods or nutrients on 
the systemic metabolism and has been widely applied to the investigation of the 
relationship between food/diet, gut microbiota and health. Indeed, the gut microbiota 
is an emerging environmental component at the crossroads of all environmental 
factors (i.e. under the influence of diet, lifestyle and exposome), which provides a 
reservoir of hundreds of thousands of unique extra genes [35-37]. It is therefore 
believed that manipulating the gut microbial ecosystem may result in health 
improvement of its host. A number of studies have used metabolic profiling 
technologies to assess the metabolic impact of the gut microbiota on its host, which 
have been reviewed here: [38,39].  
The gut microbiota is an extremely complex ecosystem and we are currently 
limited in our ability to measure the metabolic outcome of variations of specific 
groups or species of bacteria. To overcome this issue, a nutrimetabonomics 
approach has been recently applied to a prebiotic intervention study in obese women 
to link the bacterial content of human volunteers to metabolic markers of energy 
metabolism in plasma [40]. This illustrates that it is possible to decipher the impact of 
selected bacterial groups or species and their metabolism on the human host using 
such metabolic profiling approach [41]. Similarly, this can be applied to animal 
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models where the metabolism of particular organs is of easier access. For example, 
a recent work profiled the hepatic metabolism and gut bacterial community in 
response to resistant starch intake in mice fed a high fat diet [42]. This revealed 
strong associations between hepatic amino acid metabolism and gut microbial 
modulation of high relevance for human nutrition.  
Epidemiological surveys are also extremely useful to identify meaningful 
associations between diet and health. However, they often fail to detect subtle 
associations between nutrients and health due to the inevitable high degree of inter-
individual variation and poor diet records. Nonetheless, nutrimetabonomics has 
proved very useful in identifying metabolic markers of a healthy lifestyle. The 
International Collaborative Study on Macro-/Micronutrients and Blood Pressure 
(INTERMAP) study recently reported 12 urinary metabolites differentially observed in 
afro-americans versus non-hispanic white americans [43]. Of those, urinary hippuric 
acid was associated with lower blood pressure and higher polyphenol intake from 
fruits and vegetables. Hence, this NMR-based nutrimetabonomic study generated 
new hypotheses about possible links between urinary metabolites, food intake and 
cardiovascular health.  
With the recent development of Genome Wide Association Studies with 
Metabolic traits (mGWAS), there is now the potential for identifying gene variants 
associated with specific metabolic functions. Although a few studies have attempted 
such approach to link the genome with the metabolome in a nutritional context, it is 
realistic to envisage that this strategy will lead to the identification of new genetic 
variants that predispose some individuals to nutrient deficiencies or to particular 
metabolic needs. Neverheless, beyond mGWAS, epigenetic and gut microbial 
variations must also be taken into account to develop a genuine personalised 
nutrition, which should be accompanied by personalised functional foods. Indeed, 
functional foods cannot be seen as a one-size-fits-all. This is already recognised by 
the research community working on modulation of the gut microbiota and huge 
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efforts are currently pursued to stratify individuals according to their “enterotype” [44] 
to ultimately propose personalised probiotics. The same might be applied to other 
functional foods where inter-individual variability in metabolic capacities may affect 
the targetted benefit. Similarly, mGWAS have also been recently applied to plant 
science to unravel candidate genes associated with metabolic traits [45,46]. Such 
approach should be encouraged in the future in order to facilitate the production of 
functional crops carrying genetic variants associated with the production of beneficial 
compounds and/or nutrients. Assessing the metabolism is therefore essential to the 
success of such enterprise and metabolic profiling technologies will be indispensable 
to achieve this goal. 
 
Conclusion 
 
The twenty-first century is facing immense clinical challenges that include an 
overall ageing population along with a worldwide spread of metabolic disorders such 
as obesity and type 2 diabetes. The promotion of a healthy diet is an appropriate 
response to prevent such threats although high inter-individual variability driven by 
complex gene-nutrient-environment interactions calls for a more personalised 
approach that must be accompanied by the development of personalised functional 
foods. This can be supported by metabolic profiling as it can assist in developing new 
functional foods and nutrients at various stages of their elaboration. In the future, 
these technologies applied in conjonction with other ‘omics’ approaches to large-
scale mGWAS will play a major role to unravel the biological mechanisms 
underpinning inter-individual variability in response to food intake and identify new 
targets for functional ingredients.  
 
Key points: 
 
• Metabolic profiling is becoming increasingly popular to assess food 
composition, which facilitates the identification of new functional ingredients. 
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• Metabolic profiling is a powerful approach to identify new biomarkers of food 
intake and assist diet intervention and epidemiological studies by offering a 
new way to control diet records and compliance. 
• Genome Wide Association Studies with Metabolic traits are opening a new 
era in the unraveling of the complex gene-nutrient-environment interactions 
that will provide new targets for the development of functional foods. 
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Figure legend 
Figure 1: Metabolic profiling can be applied at various stages of the development of 
new functional foods. The metabolic composition of complex food matrices can be 
characterised using metabolic profiling technologies. Untargeted approaches can 
facilitate identification of new metabolites of particular interest and contribute to the 
development of new functional ingredients. Gut microbiota is an inevitable partner 
whith a degree of inter-individual variability that must be considered in the 
elaboration of functional foods, as well as being a potential target. Gut microbial 
metabolic activity is rapidly screened using metabolic profiling technologies. Diet 
intervention studies and epidemiological surveys require accurate records of food 
intake and control for diet compliance, which can be achieved by relying on the 
measurement of metabolic biomarkers of food intake. The metabolic outcome of diet 
intervention studies and Genome-Wide Association Studies with Metabolic traits 
(mGWAS) are assisted by metabolic profiling. 
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Table 1: Potential biomarkers of food intake.  
Food Product Biomarker Analytical Method Biological 
Matrix 
Ref 
Aronia-Citrus juice Proline-betaine; ferulic acid; mercapturate derivatives HPLC-qTOF-MS Urine [48] 
Brassica oleraceae N-acetyl isothiocyanates; cysteine isothiocyanates HPLC-qTOF-MS Urine [31] 
Caseinoglycomacropeptide 
(from milk) 
α-ketoisovalerate, α-hydroxybutyrate and isomers; α-hydroxyisovalerate; 
α-keto-3-methylvalerate 
LC-qTOF-MS Plasma [49] 
Citrus fruits Proline-betaine; hesperetin-glucuronide UPLC-qTOF-MS Urine [29] 
Cocoa Theobromine, 6-amino-5-[N-methylformylamino]-1-methyluracil; 7-
methyluric acid 
UPLC-qTOF-MS Urine [29] 
Coffee Quinate; paraxanthine; 5-acetylamino-6-amino-3-methyluracil; 1,7-
dimethylurate; α-methylurate; 1-methylxanthine; caffeine; 1,3,7-
trimethylurate; 7-methylxanthine 
GC-MS and LC-MS Serum [28] 
Egg Docosapentaenoate GC-MS and LC-MS Serum [28] 
Fiber intake 2,6-dihydroxybenzoic acid; 2-aminophenol sulfate LC-qTOF-MS Plasma [50] 
Fish & Seafood Eicosapentaenoate, docosahexaenoate GC-MS and LC-MS Serum [28] 
 TMAO UPLC-qTOF-MS Urine [31] 
Fruit juice Glycerate; stachydrine; N-methylproline; threonate; scyllo-inositol; 
homostachydrine 
GC-MS and LC-MS Serum [28] 
Nuts & Peanut butter Tryptophan betaine; 2-methylbutyroylcarnitine; 4-vinylphenol sulfate; 5α-
androstan-3β,17β-diol disulfate; 4-androsten-3β,17β-diol disulfate 
GC-MS and LC-MS Serum [28] 
Red Cabbage Hippuric acid derivatives; acetyl-cysteine conjugates of isothiocyanates;  UPLC-qTOF-MS Urine [29] 
Rye bread 2-aminophenol sulfate; nonanedioic acid; indolylacryloylglycine; 
enterolactone glucuronide; ferulic acid-4-O-sulfate 
UPLC-qTOF-MS Urine [51] 
Walnut Indolic compounds; conjugated urolithin HPLC-qTOF-MS Urine [52] 
 5-hydroxyindole-3-acetic acid UPLC-qTOF-MS Urine [29] 
Refined Wheat bread Ascorbic acid (industrial additive); Quinic acid UPLC-qTOF-MS Urine [51] 
Whey concentrate hydrolysate pGlu-Leu; Methionine sulfoxide; N-phenylacetyl-methionine; N-
phenylacetyl-methionine sulfoxide; pGlu-Val 
LC-qTOF-MS Plasma [49] Modified	  from	  [47].	  
 
